Given that after NPS treatment of the C3.43 tumor cells we found an increase in lymphocytes present within tumors but were not able to identify CD8+ T cells that responded to known antigens, we next examined whether selective depletion of CD8+ or CD4+ cells would result in changes in the growth rate of re-challenge tumors. This evidence concerns the gene CD4 and neoplasm.